Lysophosphatidic acid enhances survival of human CD34+ cells in ischemic conditions
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lysophosphatidic acid enhances survival of human CD34+ cells in ischemic conditions
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-11-10
DOI
10.1038/srep16406
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: Design of the RENEW study
- (2013) Thomas J. Povsic et al. AMERICAN HEART JOURNAL
- Lysophosphatidic acid promotes secretion of VEGF by increasing expression of 150-kD Oxygen-regulated protein (ORP150) in mesenchymal stem cells
- (2013) Hua Wei et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Improving survival and efficacy of pluripotent stem cell-derived cardiac grafts
- (2013) Creighton W. Don et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Lysophosphatidic Acid Mediates Myeloid Differentiation within the Human Bone Marrow Microenvironment
- (2013) Denis Evseenko et al. PLoS One
- Lysophosphatidic Acid Protects Human Mesenchymal Stromal Cells from Differentiation-Dependent Vulnerability to Apoptosis
- (2013) Bernard Y.K. Binder et al. TISSUE ENGINEERING PART A
- Sonic Hedgehog–Modified Human CD34+ Cells Preserve Cardiac Function After Acute Myocardial Infarction
- (2012) Alexander R. Mackie et al. CIRCULATION RESEARCH
- Growth Induction and Low-Oxygen Apoptosis Inhibition of Human CD34+Progenitors in Collagen Gels
- (2012) Daniele Avitabile et al. Biomed Research International
- PPAR-γ and AMPK – Advantageous targets for myocardial ischemia/reperfusion therapy
- (2011) Alex Morrison et al. BIOCHEMICAL PHARMACOLOGY
- Regulation of Mammalian Physiology, Development, and Disease by the Sphingosine 1-Phosphate and Lysophosphatidic Acid Receptors
- (2011) Victoria A. Blaho et al. CHEMICAL REVIEWS
- Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina
- (2011) Douglas W. Losordo et al. CIRCULATION RESEARCH
- Exosomes From Human CD34 + Stem Cells Mediate Their Proangiogenic Paracrine Activity
- (2011) Susmita Sahoo et al. CIRCULATION RESEARCH
- Interleukin-4 and interleukin-13 prime migrational responses of haemopoietic progenitor cells to stromal cell-derived factor-1α
- (2011) N. Punia et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Improved Survival, Vascular Differentiation and Wound Healing Potential of Stem Cells Co-Cultured with Endothelial Cells
- (2011) Dora C. S. Pedroso et al. PLoS One
- Lysophosphatidic Acid Induces Erythropoiesis through Activating Lysophosphatidic Acid Receptor 3
- (2011) Chi-Ling Chiang et al. STEM CELLS
- LPA Receptors: Subtypes and Biological Actions
- (2010) Ji Woong Choi et al. Annual Review of Pharmacology and Toxicology
- Human embryonic stem cell-derived microvascular grafts for cardiac tissue preservation after myocardial infarction
- (2010) Thomas P. Kraehenbuehl et al. BIOMATERIALS
- Human CD34 + Cells in Experimental Myocardial Infarction
- (2010) Jingxiong Wang et al. CIRCULATION RESEARCH
- LPA rescues ER stress-associated apoptosis in hypoxia and serum deprivation-stimulated mesenchymal stem cells
- (2010) Zongwei Li et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem Cells
- (2010) Anthony E. Boitano et al. SCIENCE
- Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation
- (2009) J. Hoggatt et al. BLOOD
- Cell Therapy Attenuates Cardiac Dysfunction Post Myocardial Infarction: Effect of Timing, Routes of Injection and a Fibrin Scaffold
- (2009) Juliana S. Nakamuta et al. PLoS One
- Lysophosphatidic Acid Protects Mesenchymal Stem Cells Against Ischemia-Induced Apoptosis In Vivo
- (2009) Xuebin Liu et al. STEM CELLS AND DEVELOPMENT
- Effects of erythropoietin after an acute myocardial infarction: Rationale and study design of a prospective, randomized, clinical trial (HEBE III)
- (2008) Anne M. Belonje et al. AMERICAN HEART JOURNAL
- LPA modulates monocyte migration directly and via LPA-stimulated endothelial cells
- (2008) Cindy Gustin et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Genetic Enhancement of Stem Cell Engraftment, Survival, and Efficacy
- (2008) Marc S. Penn et al. CIRCULATION RESEARCH
- Macrophage roles following myocardial infarction
- (2008) Jessica M. Lambert et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Strategies to promote donor cell survival: Combining preconditioning approach with stem cell transplantation
- (2008) Husnain Kh Haider et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Systems approaches to preventing transplanted cell death in cardiac repair
- (2008) Thomas E. Robey et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction
- (2008) Barry M. Massie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lysophosphatidic Acid Protects Mesenchymal Stem Cells Against Hypoxia and Serum Deprivation-Induced Apoptosis
- (2007) Jinghai Chen et al. STEM CELLS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now